Preclinical pharmacokinetic and pharmacology evaluations of agents being developed for cancer patients. Period of performance 7/1/2016 - 6/30/2021.

Ended Awarded Last action

Contract number
HHSN261201600024I
Awardee
Awarding agency
Task orders
4 $479,967 obligated

Award facts

Combined order value
  • $479,967 Current, with exercised options
  • $591,746 Potential, with all options
Last date to order 100% complete
IDV ceiling 5% used
$9,900,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201600024I?

HHSN261201600024I was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on July 1, 2016.

How much is contract HHSN261201600024I worth?

Orders under HHSN261201600024I have obligated $479,967. Their combined potential value, with all options, is $591,746. HHSN261201600024I's own ceiling is $9,900,000.

How many orders have been placed under contract HHSN261201600024I?

4 orders have been placed under HHSN261201600024I, the latest on September 13, 2019.

Who can order from contract HHSN261201600024I?

HHSN261201600024I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201600024I part of a contract vehicle?

Yes. HHSN261201600024I is part of Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.

Was contract HHSN261201600024I competed?

The extent of competition for HHSN261201600024I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV